SynGEM publication paper of the month on ReSViNET


#ReSViNET , the Respiratory Syncytial Virus Network, selected the recent publication in AJRCCM on the SynGEM Phase I clinical trial as paper of the month March. The study which was executed by Imperial College London, showed that #SynGEM is safe and capable of inducing long term immune responses. A commentary published in the same journal suggested to test the vaccine in a human challenge study. The author manuscript can now be downloaded free of charge from the ReSViNET website

Featured Posts
Recent Posts
Archive
Search By Tags
Follow Us
  • Twitter Social Icon
  • LinkedIn Social Icon